The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 2
- 2 new
- Median first-year cost
- $299,182
- $598,364 in all
- Institutions
- 2
- 2 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
2
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- IMMUNOSHIELD THERAPEUTICS INC.1
- STEMBIOSYS, INC.1
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-J (O2))1
- Special Emphasis Panel (ZDK1 GRB-T (M1))1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2023 | Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation1R43DK135102-01 | Navarro, Mary M | STEMBIOSYS, INC., TX | First-year cost $300,000 | Study section ZDK1 |
| FY2023 | Islet dosing and loading density in injection molded macroencapsulation devices1R43DK136496-01 | Snir, OrenWeaver, Jessica Diane | IMMUNOSHIELD THERAPEUTICS INC., AZ | First-year cost $298,364 | Study section ZDK1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.